A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337
Status:
Completed
Trial end date:
2017-06-13
Target enrollment:
Participant gender:
Summary
A randomized, open-label, single oral dose, 2-way crossover clinical trial to compare safety
and pharmacokinetic characteristics of CKD-337 in healthy male volunteers